🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The success of the U.S. vaccination program against SARS-Cov-2 is shown by ...
Status
Terminated
Location
Griffin Hospital
Start Date
2021-10-15
Trial ID
NCT05081271
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
PRIBIVAC will assess a heterologous prime-boost-boost strategy in compariso...
Status
Completed
Location
National Centre for Infectious Diseases (NCID)
Start Date
2021-10-12
Trial ID
NCT05142319
Treatments Being Tested
This is a randomized, double-blinded, placebo-controlled, dose-escalation s...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06
Trial ID
NCT05609045
Treatments Being Tested
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel cor...
Status
Completed
Location
Victoria Biomedical Research Institute
Start Date
2022-05-18
Trial ID
NCT07408297
Phase 2 clinical trial in adults previously vaccinated against SARS-CoV-2 i...
Status
Completed
Location
Universidad del Desarrollo - Clínica Alemana
Start Date
2022-11-28
Trial ID
NCT05593042
Treatments Being Tested
In this prospective study, SARS-CoV-2 spike protein specific total immunogl...
Status
Completed
Location
University of Debrecen
Start Date
2021-11-16
Trial ID
NCT05547802
Treatments Being Tested
Coronavirus disease 2019 (COVID-19) is potentially a deadly disease caused ...
Status
Completed
Location
Royal College of Surgeons in Ireland - Bahrain
Start Date
2021-07-18
Trial ID
NCT04993560
Treatments Being Tested
The primary objective was to assess the safety and tolerability of 2 differ...
Status
Completed
Location
University Hospitals Birmingham NHS
Start Date
2021-09-16
Trial ID
NCT05148962
Treatments Being Tested